552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study
Introduction: The COVID-19 pandemic was officially declared in the United States by the Centers for disease control and prevention (CDC) on January 5, 2020. Methicillin-resistant Staphylococcus aureus (MRSA) can cause post-viral pneumonia. We wanted to study the impact of the pandemic on patients ad...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , , , , , , |
| التنسيق: | article |
| منشور في: |
2024
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/15954 https://doi.org/10.1097/01.ccm.0001000384.11380.59 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.lww.com/ccmjournal/fulltext/2024/01001/552__the_impact_of_the_covid_19_pandemic_on_mrsa.500.aspx |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| _version_ | 1864513471803031553 |
|---|---|
| author | El Labban, Mohamad |
| author2 | Chaaban, Toufic Aboelnasr, Amr Vo, Natasha Olorode, Gbemisola Niaz, Fayreal Anjum Khan, Syed Wahab, Abdul |
| author2_role | author author author author author author author |
| author_facet | El Labban, Mohamad Chaaban, Toufic Aboelnasr, Amr Vo, Natasha Olorode, Gbemisola Niaz, Fayreal Anjum Khan, Syed Wahab, Abdul |
| author_role | author |
| dc.creator.none.fl_str_mv | El Labban, Mohamad Chaaban, Toufic Aboelnasr, Amr Vo, Natasha Olorode, Gbemisola Niaz, Fayreal Anjum Khan, Syed Wahab, Abdul |
| dc.date.none.fl_str_mv | 2024-08-05T06:57:08Z 2024-08-05T06:57:08Z 2024 2024-01 |
| dc.identifier.none.fl_str_mv | 0090-3493 http://hdl.handle.net/10725/15954 https://doi.org/10.1097/01.ccm.0001000384.11380.59 El Labban, M., Chaaban, T., Aboelnasr, A., Vo, N., Olorode, G., Niaz, F., ... & Wahab, A. (2024). 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study. Critical Care Medicine, 52(1), S249. http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.lww.com/ccmjournal/fulltext/2024/01001/552__the_impact_of_the_covid_19_pandemic_on_mrsa.500.aspx |
| dc.language.none.fl_str_mv | en |
| dc.relation.none.fl_str_mv | Critical Care Medicine |
| dc.rights.*.fl_str_mv | info:eu-repo/semantics/openAccess |
| dc.title.none.fl_str_mv | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study |
| dc.type.none.fl_str_mv | Article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/article |
| description | Introduction: The COVID-19 pandemic was officially declared in the United States by the Centers for disease control and prevention (CDC) on January 5, 2020. Methicillin-resistant Staphylococcus aureus (MRSA) can cause post-viral pneumonia. We wanted to study the impact of the pandemic on patients admitted with MRSA pneumonia. Methods: Using the National Inpatient Sample Database 2017 to 2020, we conducted a retrospective study of adult patients admitted with MRSA pneumonia according to ICD-10 codes. Several demographics and comorbidities were analyzed. Chi square analysis and two sample t-test were used for statistical analysis, p value < 0.05 was considered significant. Results: Patients were studied in two categories by year: 2017-2019 vs. 2020 admissions. MRSA pneumonia admissions in 2020 (5545) were less than in 2017 (6270), 2018 (8635) and 2019 (7485). Both groups had similar baseline patient characteristics, 50% were females, around 80% were Caucasian white, and the mean age was around 66 years. The percentage of patients with a Carlson Comorbidity Index score of 3 or more was around 52% in both groups, p-value 0.75. Statistically significant comorbidities noticed in the 2020 group included cigarette smoking (16% vs. 12%), supraventricular tachycardia (30% vs. 23%), obesity (20% vs. 16.7%), and chronic kidney disease (18% vs. 15%) (all had a p value less than 0.05). Mortality was higher in the 2020 group (365 (6.5%) vs. 2017 (355, 5.6%), 2018 (415, 4.8%), and 2019 (400, 5.3%) however not statistically significant among the two groups (6.5% vs. 5.2%, p-value 0.07). Rates of septic shock were higher in the 2020 group (165 (3%) vs. 2017 (125, 2%), 2018 (140, 1.6%), and 2019 (145, 1.9%) (3% vs. 1.8%, p-value 0.01). Rates of mechanical ventilation were higher in the 2020 group (850 (15.3%) vs. 2017 (725, 11.5%), 2018 (1050, 12.1%), and 2019 (815, 10.8%) (15.3% vs. 11.5%, p value < 0.01). The mean length of stay was higher in the 2020 group (9.9 days vs. 2017 (8.89 days), 2018 (8.91 days), and 2019 (8.94 days). The mean admission total charge was higher in the 2020 group (105792 $ vs. 2017 (78516$), 2018 (83538$), and 2019 (91031$). Conclusions: The patients across the 4 years had similar baseline epidemiological and clinical (comorbid) characteristics and yet, patients admitted in 2020 had worse outcomes. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | LAURepo_c6d5b45587fa00233bb267d23aacc191 |
| identifier_str_mv | 0090-3493 El Labban, M., Chaaban, T., Aboelnasr, A., Vo, N., Olorode, G., Niaz, F., ... & Wahab, A. (2024). 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study. Critical Care Medicine, 52(1), S249. |
| language_invalid_str_mv | en |
| network_acronym_str | LAURepo |
| network_name_str | Lebanese American University repository |
| oai_identifier_str | oai:laur.lau.edu.lb:10725/15954 |
| publishDate | 2024 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| spelling | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient studyEl Labban, MohamadChaaban, TouficAboelnasr, AmrVo, NatashaOlorode, GbemisolaNiaz, FayrealAnjum Khan, SyedWahab, AbdulIntroduction: The COVID-19 pandemic was officially declared in the United States by the Centers for disease control and prevention (CDC) on January 5, 2020. Methicillin-resistant Staphylococcus aureus (MRSA) can cause post-viral pneumonia. We wanted to study the impact of the pandemic on patients admitted with MRSA pneumonia. Methods: Using the National Inpatient Sample Database 2017 to 2020, we conducted a retrospective study of adult patients admitted with MRSA pneumonia according to ICD-10 codes. Several demographics and comorbidities were analyzed. Chi square analysis and two sample t-test were used for statistical analysis, p value < 0.05 was considered significant. Results: Patients were studied in two categories by year: 2017-2019 vs. 2020 admissions. MRSA pneumonia admissions in 2020 (5545) were less than in 2017 (6270), 2018 (8635) and 2019 (7485). Both groups had similar baseline patient characteristics, 50% were females, around 80% were Caucasian white, and the mean age was around 66 years. The percentage of patients with a Carlson Comorbidity Index score of 3 or more was around 52% in both groups, p-value 0.75. Statistically significant comorbidities noticed in the 2020 group included cigarette smoking (16% vs. 12%), supraventricular tachycardia (30% vs. 23%), obesity (20% vs. 16.7%), and chronic kidney disease (18% vs. 15%) (all had a p value less than 0.05). Mortality was higher in the 2020 group (365 (6.5%) vs. 2017 (355, 5.6%), 2018 (415, 4.8%), and 2019 (400, 5.3%) however not statistically significant among the two groups (6.5% vs. 5.2%, p-value 0.07). Rates of septic shock were higher in the 2020 group (165 (3%) vs. 2017 (125, 2%), 2018 (140, 1.6%), and 2019 (145, 1.9%) (3% vs. 1.8%, p-value 0.01). Rates of mechanical ventilation were higher in the 2020 group (850 (15.3%) vs. 2017 (725, 11.5%), 2018 (1050, 12.1%), and 2019 (815, 10.8%) (15.3% vs. 11.5%, p value < 0.01). The mean length of stay was higher in the 2020 group (9.9 days vs. 2017 (8.89 days), 2018 (8.91 days), and 2019 (8.94 days). The mean admission total charge was higher in the 2020 group (105792 $ vs. 2017 (78516$), 2018 (83538$), and 2019 (91031$). Conclusions: The patients across the 4 years had similar baseline epidemiological and clinical (comorbid) characteristics and yet, patients admitted in 2020 had worse outcomes.Published2024-08-05T06:57:08Z2024-08-05T06:57:08Z20242024-01Articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article0090-3493http://hdl.handle.net/10725/15954https://doi.org/10.1097/01.ccm.0001000384.11380.59El Labban, M., Chaaban, T., Aboelnasr, A., Vo, N., Olorode, G., Niaz, F., ... & Wahab, A. (2024). 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study. Critical Care Medicine, 52(1), S249.http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.phphttps://journals.lww.com/ccmjournal/fulltext/2024/01001/552__the_impact_of_the_covid_19_pandemic_on_mrsa.500.aspxenCritical Care Medicineinfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/159542024-08-05T10:41:26Z |
| spellingShingle | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study El Labban, Mohamad |
| status_str | publishedVersion |
| title | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study |
| title_full | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study |
| title_fullStr | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study |
| title_full_unstemmed | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study |
| title_short | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study |
| title_sort | 552: The impact of the COVID-19 pandemic on MRSA pneumonia admissions: a national inpatient study |
| url | http://hdl.handle.net/10725/15954 https://doi.org/10.1097/01.ccm.0001000384.11380.59 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://journals.lww.com/ccmjournal/fulltext/2024/01001/552__the_impact_of_the_covid_19_pandemic_on_mrsa.500.aspx |